This is because it directly targets cancer cells, reducing the negative effects associated with more conventional treatments.

Researchers conducted a retrospective cohort study of 34,248 women diagnosed with locoregional breast cancer who received ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

Acquisition of mesenchymal markers during the epithelial–mesenchymal ... in the molecular characterization of breast cancer CTCs. HER2 and hormonal receptors can change during breast cancer ...

The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.

Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...

By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.